Oncolytics Biotech Inc ONCY

Roche for the buyout

[CaseyL]

Arguably pancreatic cancer is the most unique on going trial. If there's great success, it's the one that stands out. There hasn't been much success or improvement with pancreatic cancer in too many years. With that being said, we can't forget the mega parade float with PanCan. I'm sure things are quite intense as far as business aspects. I'm putting my money on Roche.

[Azzak34]

There's an argument for Merck too but may very well be Roche. Given the consistent results and great safety profile you'd think there may be a few making enquiries. Interesting times for sure. 

[Peladawn]

Casey... you’re exactly spot-on....I’m sure things are intense right now, regarding business aspects.....when you’re dealing in multiple billion dollar numbers, it can be very intense indeed, and it takes a little more time

[Buckhenry]

We dont know that anything is going on unless you have a seat in the boardroom. We don't know that anything will come out of next week that will move this stock higher. We have been hoping since god was a kid but nothing to date. These pumpers have filled us with this same garbage for years. I will just wait for the official news release. Maybe Matt can give another fireside chat to make us

[Azzak34]

All those words and you couldn't "stock" the landing!   

[2O2Ovision]

At the very least and for patients' sake, Pancan should be able to move this along quicker with its ongoing sites, FDA relationship, public support and lobbying etc than a corporate entity would. Roche certainly doesn't need a charity to run a trial for them but they will have a pretty clear investment case for their shareholders with the go-no-go decision in 2025 for a full PIII

[jh1970]

Why 2025 ?

[2O2Ovision]

In one the recent webcasts (see ONC website) they explained that the pre-trial starting next quarter +/- expects the interim results around mid 2025 in order to move into the next phase.

[fox7mf]

I'm sure it'll be Roche to jump in at some pt, but I see an argument for Merck as well. The cheer squad will have you thinking every major under the sun is just throwing offers at Oncy in desperate attempts to outbid each other. That is certainly not clear, but what is clear is that Azz had to create a 2nd account (peladawn...lol) so someone would finally support his "arguments."

[2O2Ovision]

I am siding with Roche as well for the simple fact Pancan is likely laying out the ground work with the FDA based on the use of Tecentric (based on Matt's "Roche" comment on the webcast). Merck's keytruda certainly has a history with pela in several indications as well but I'm just following the path of least resistance. 

[Azzak34]

Haha yes, I am all the people! Amazing that a guy would reference you in a post while having you blocked! Can someone ask that coward Fox why he continues to talk about me while not allowing me to retort? Seems like a poosy move, I'm sure you agree. 

[fox7mf]

We need BIG partnership news. November 7 2022 we received the astounding Goblet data update. Soon after COFFEY promised the next 6 to 9 months would be the most exciting and important in ONCY history. Nov 8th 2022 the SP was at $2.38 cad. Almost 1 year later the SP sits at $2.16 cad. Is that exciting or what?!?